Sign up to save your podcasts
Or
Share Ep 52: Mental Health, Cancer, and the Gut Data We're Not Using
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ep 52: Mental Health, Cancer, and the Gut Data We're Not Using
We talk a lot about "data-driven healthcare," yet we're still blind to one of the most important data layers: the microbiome.
Mental health, early-onset cancer, autoimmunity—much of that risk is already visible in the gut years before a diagnosis code ever hits the chart. Most care models, benefits designs, and longevity strategies simply don't account for it.
In this episode of Boombostic Health, I sit down with Paul Denslow, CEO & co-founder of Intus Bio, to dig into how GutID turns the microbiome into hard infrastructure: high-resolution gut data, a score you can track, and a way to see whether your interventions are actually moving risk—not just spend.
In this episode, we cover:-
Why microbiome disruption often precedes mental health issues and cancer
-
How GutID converts millions of bacterial data points into a single, trackable gut score
-
Why behavioral health and functional practitioners have been early adopters
-
The problem with "just take a probiotic" in the absence of baseline gut data
-
How AI + high-resolution microbiome testing open a real prevention window
-
What a serious prevention and longevity strategy looks like when gut data is included
If you're responsible for care delivery, benefits strategy, or long-term risk, ignoring this data layer is no longer a neutral decision.
Watch the full conversation to see why mental health, cancer, and your "bacterial you" belong at the center of modern prevention.
About our guest:
Paul Denslow is the CEO and co-founder of Intus Bio, the company behind GutID. With a background in finance and big data, Paul partnered with co-founder Mark Driscoll, a pioneer in next-generation sequencing, to build a platform that treats the microbiome as a hard data problem—not a mystery. Intus Bio's GutID test and Titan 1 platform are used by clinicians and practitioners to generate high-resolution microbiome data that can be translated into actionable prevention and disease insights.
Links & Resources:
Learn more about GutID: https://www.gutid.com/collections/all
Learn more about Intus Bio: https://www.intusbio.com/gutid
Watch more Boombostic Health episodes: https://www.boombostichealth.com/podcast
View all episodes
By Bradley BosticWe talk a lot about "data-driven healthcare," yet we're still blind to one of the most important data layers: the microbiome.
Mental health, early-onset cancer, autoimmunity—much of that risk is already visible in the gut years before a diagnosis code ever hits the chart. Most care models, benefits designs, and longevity strategies simply don't account for it.
In this episode of Boombostic Health, I sit down with Paul Denslow, CEO & co-founder of Intus Bio, to dig into how GutID turns the microbiome into hard infrastructure: high-resolution gut data, a score you can track, and a way to see whether your interventions are actually moving risk—not just spend.
In this episode, we cover:-
Why microbiome disruption often precedes mental health issues and cancer
-
How GutID converts millions of bacterial data points into a single, trackable gut score
-
Why behavioral health and functional practitioners have been early adopters
-
The problem with "just take a probiotic" in the absence of baseline gut data
-
How AI + high-resolution microbiome testing open a real prevention window
-
What a serious prevention and longevity strategy looks like when gut data is included
If you're responsible for care delivery, benefits strategy, or long-term risk, ignoring this data layer is no longer a neutral decision.
Watch the full conversation to see why mental health, cancer, and your "bacterial you" belong at the center of modern prevention.
About our guest:
Paul Denslow is the CEO and co-founder of Intus Bio, the company behind GutID. With a background in finance and big data, Paul partnered with co-founder Mark Driscoll, a pioneer in next-generation sequencing, to build a platform that treats the microbiome as a hard data problem—not a mystery. Intus Bio's GutID test and Titan 1 platform are used by clinicians and practitioners to generate high-resolution microbiome data that can be translated into actionable prevention and disease insights.
Links & Resources:
Learn more about GutID: https://www.gutid.com/collections/all
Learn more about Intus Bio: https://www.intusbio.com/gutid
Watch more Boombostic Health episodes: https://www.boombostichealth.com/podcast